• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

处理患者水平数据经济评估中的不确定性:使用贝叶斯方法为卫生技术评估提供信息的综述。

Handling uncertainty in economic evaluations of patient level data: a review of the use of Bayesian methods to inform health technology assessments.

机构信息

Department of Clinical Epidemiology & Biostatistics, McMaster University, Programs for Assessment of Technology in Health (PATH) Research Institute, Ontario, Canada.

出版信息

Int J Technol Assess Health Care. 2009 Oct;25(4):546-54. doi: 10.1017/S0266462309990316.

DOI:10.1017/S0266462309990316
PMID:19845985
Abstract

OBJECTIVES

Due to potential advantages (e.g., using all available evidence), Bayesian methods have been proposed to assist healthcare decision making. This review provides a detailed description of how Bayesian methods have been applied to economic evaluations of patient level data. The results serve both as a reference and as a means by which to examine the appropriate application of Bayesian methods to inform decision making.

METHODS

MEDLINE, EMBASE, and Cochrane Economic Evaluation databases were searched to identify studies, published up to November 2007, meeting three inclusion criteria: (i) the study conducted an economic evaluation, (ii) sampling uncertainty was incorporated using Bayesian methods, (iii) the likelihood function was informed by patient level data from a single source. Data were collected on key study characteristics (e.g., prior distribution, likelihood function, presentation of uncertainty).

RESULTS

The search identified 366 potentially relevant studies, from which 103 studies underwent full-text review. Sixteen studies met the inclusion criteria. Half of the studies used uninformative priors; most studies incorporated the potential dependence between costs and effects, and presented cost-effectiveness acceptability curves. Results were sensitive to changes in the priors and likelihoods.

CONCLUSIONS

Limited use of informative priors, among the included studies, gives policy makers little guidance on one of the main benefits of Bayesian methods, the ability to integrate all available evidence to capture the uncertainty inherent in decision making.

摘要

目的

由于潜在的优势(例如,使用所有可用的证据),贝叶斯方法已被提出以协助医疗保健决策。本综述详细描述了贝叶斯方法如何应用于患者水平数据的经济评估。这些结果既是参考,也是检验贝叶斯方法在为决策提供信息方面的适当应用的手段。

方法

检索 MEDLINE、EMBASE 和 Cochrane 经济评价数据库,以确定符合以下三项纳入标准的研究:(i)进行经济评价的研究,(ii)使用贝叶斯方法纳入抽样不确定性,(iii)似然函数由来自单一来源的患者水平数据提供。收集了关键研究特征的数据(例如,先验分布、似然函数、不确定性的表示)。

结果

搜索确定了 366 项潜在相关研究,其中 103 项进行了全文审查。符合纳入标准的研究有 16 项。半数研究使用了无信息先验;大多数研究纳入了成本和效果之间的潜在依赖性,并呈现了成本效果可接受性曲线。结果对先验和似然的变化敏感。

结论

在所纳入的研究中,对信息丰富的先验的使用有限,这使得决策者对贝叶斯方法的主要优势之一(即整合所有可用证据以捕捉决策中固有的不确定性的能力)几乎没有指导意义。

相似文献

1
Handling uncertainty in economic evaluations of patient level data: a review of the use of Bayesian methods to inform health technology assessments.处理患者水平数据经济评估中的不确定性:使用贝叶斯方法为卫生技术评估提供信息的综述。
Int J Technol Assess Health Care. 2009 Oct;25(4):546-54. doi: 10.1017/S0266462309990316.
2
Complementing the net benefit approach: a new framework for Bayesian cost-effectiveness analysis.补充净收益方法:贝叶斯成本效益分析的新框架。
Int J Technol Assess Health Care. 2009 Oct;25(4):537-45. doi: 10.1017/S0266462309990444.
3
Contribution of economic evaluation to decision making in early phases of product development: a methodological and empirical review.经济评估对产品开发早期阶段决策的贡献:方法与实证综述。
Int J Technol Assess Health Care. 2008 Fall;24(4):465-72. doi: 10.1017/S0266462308080616.
4
Approaches for economic evaluations of health care technologies.医疗保健技术的经济评估方法。
J Am Coll Radiol. 2009 May;6(5):307-16. doi: 10.1016/j.jacr.2009.01.011.
5
Modelling in the economic evaluation of health care: selecting the appropriate approach.医疗保健经济评估中的建模:选择合适的方法。
J Health Serv Res Policy. 2004 Apr;9(2):110-8. doi: 10.1258/135581904322987535.
6
[Meta-analysis of the Italian studies on short-term effects of air pollution].[意大利关于空气污染短期影响研究的荟萃分析]
Epidemiol Prev. 2001 Mar-Apr;25(2 Suppl):1-71.
7
Health economic evaluations: how to find them.卫生经济评估:如何找到它们。
Int J Technol Assess Health Care. 2006 Fall;22(4):512-7. doi: 10.1017/S0266462306051452.
8
Modeling the value for money of changing clinical practice change: a stochastic application in diabetes care.对改变临床实践的性价比进行建模:糖尿病护理中的随机应用。
Med Care. 2009 Oct;47(10):1053-61. doi: 10.1097/MLR.0b013e31819e1ee9.
9
Economic evaluations conducted by Canadian health technology assessment agencies: where do we stand?加拿大卫生技术评估机构进行的经济评估:我们目前的状况如何?
Int J Technol Assess Health Care. 2008 Fall;24(4):437-44. doi: 10.1017/S0266462308080574.
10
How well do search filters perform in identifying economic evaluations in MEDLINE and EMBASE.检索过滤器在 MEDLINE 和 EMBASE 中识别经济评估的效果如何。
Int J Technol Assess Health Care. 2009 Oct;25(4):522-9. doi: 10.1017/S0266462309990523.

引用本文的文献

1
Bayesian Cost-Effectiveness Analysis Using Individual-Level Data is Sensitive to the Choice of Uniform Priors on the Standard Deviations for Costs in Log-Normal Models.使用个体水平数据的贝叶斯成本效益分析对对数正态模型中成本标准差的均匀先验选择敏感。
Pharmacoeconomics. 2025 Aug 12. doi: 10.1007/s40273-025-01511-1.
2
Towards a New Framework for Addressing Structural Uncertainty in Health Technology Assessment Guidelines.迈向应对卫生技术评估指南中结构不确定性的新框架。
Pharmacoeconomics. 2018 Feb;36(2):127-130. doi: 10.1007/s40273-017-0603-4.